rethinkPeptides Search
Menu
Research citation

Topical administration of lacritin is a novel therapy for aqueous-deficient dry eye disease.

evidence

This record provides bibliographic details and links to the original research. An editorial study breakdown is not available.

Read the original research

Topical administration of lacritin is a novel therapy for aqueous-deficient dry eye disease.

Investigative ophthalmology & visual science, 55(8), 5401-9

Citation

Vijmasi, Trinka; Chen, Feeling Y T; Balasubbu, Suganthalakshmi; Gallup, Marianne; McKown, Robert L; Laurie, Gordon W; McNamara, Nancy A. (2014). Topical administration of lacritin is a novel therapy for aqueous-deficient dry eye disease.. Investigative ophthalmology & visual science, 55(8), 5401-9. https://doi.org/10.1167/iovs.14-13924